The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial (125598)
ARTG Name
NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial
Product name
NAGLAZYME galsulfase-rch 5mg/5mL concentrated solution for injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Ingredients
Galsulfase
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information